Advertisements


Genentech submits sNDA to FDA for Venclexta

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 12th, 2018

Dova submits sNDA for DOPTELET for chronic ITP treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 4th, 2018

Tesaro, Clovis Rally on FDA Priority Review for Lynparza sNDA

PARP inhibitor makers get a boost following priority review for AstraZeneca???s (AZN) label expansion application for Lynparza as a first-line maintenance treatment for ovarian cancer. Shares of TESARO, Inc. TSRO and Clovis Oncology.....»»

Category: worldSource: nytNov 14th, 2018

Eli Lilly submits NDA for lasmiditan, gets breakthrough designation for Emgality

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2018

AstraZeneca"s Lynparza Gets Priority Review in 1st Line Use

AstraZeneca (AZN) and partner Merck's sNDA looking for label expansion of Lynparza in the first-line setting gets FDA's priority review. .....»»

Category: dealsSource: nytNov 13th, 2018

Eyenovia submits IND for MicroStat to FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2018

Genentech says Tecentriq/Abraxane combination granted Priority Review by FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 13th, 2018

AstraZeneca, Merck: FDA accepts sNDA for LYNPARZA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

Incyte granted FDA priority review for ruxolitinib sNDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 25th, 2018

Shire submits second FDA submission for Georgia manufacturing facility

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 25th, 2018

The FDA Approved the First Big New Flu Drug in Almost 20 Years—And Is Approaching a Drug Approval Record

Shionogi and Genentech's Xofluza may treat certain people's .....»»

Category: europeSource: fortuneOct 24th, 2018

Genentech announces FDA approval of Xofluza for influenza

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2018

DBV submits Biologics License Application to FDA for Viaskin Peanut

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 22nd, 2018

Genentech Tecentriq plus chemo as initial treatment helped people with NSCLC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 22nd, 2018

Genentech"s Tecentriq, Abraxane combo demonstrates positive Phase III results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 21st, 2018

Roche reports FDA approves label update for Genentech"s Rituxan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 19th, 2018

Achaogen submits MAA to EMA for Plazomicin for cUTI treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 17th, 2018

AbbVie"s sNDA for Imbruvica combination granted priority review by FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 17th, 2018

Allergan announces FDA approval for Medicines360"s sNDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 16th, 2018

Kala Pharmaceuticals submits NDA to FDA for KPI-121 0.25% for dry eye disease

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 16th, 2018

Genentech says Phase III KATHERINE study met primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 15th, 2018